Teva Reports Gap In Tardive Dyskinesia Diagnosis Among Patients With Mood Disorders
18/5 14:26
(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA) on Monday announced new real-world data from the IMPACT-TD Registry showing a significant gap in diagnosing tardive dyskinesia in patients with underlying mood disorders....